Idiopathic pulmonary fibrosis (IPF) is still a disease in which patients' clinical needs and the delivery of palliative care (PC) are mismatched. International societies recommend integrating PC for all individuals with chronic respiratory diseases, regardless of age or prognosis [1], but early PC referral remains uncommon in IPF. Several factors contribute to this gap: the misconception that PC equals to end-of-life care, the variable clinical trajectories that characterise IPF, and the practical difficulty of determining the appropriate timing and intensity of PC for everyone [2,3].
